Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency.

Journal of pediatric endocrinology & metabolism : JPEM - 1 Sept 2003

Munns C F J, Berry M, Vickers D, Rappold G A, Hyland V J, Glass I A, Batch J A

Abstract excerpt

Leri-Weill syndrome (LWS) is a skeletal dysplasia with mesomelic short stature, bilateral Madelung deformity (BMD) and SHOX (short stature homeobox-containing gene) haploinsufficiency. The effect of 24 months of recombinant human growth hormone (rhGH) therapy on the stature and BMD of two females...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arm
Share to Body Height
Share to Growth Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Growth Hormone

Share to Radiography

Share to Short Stature Homeobox Protein

Source

Identifiers

PMID: 14513876
DOI: 10.1515/jpem.2003.16.7.997

Genes

SHOX
SDS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14513876-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency.PMID 14513876Read ↗

Height outcome of the recombinant human growth hormone treatment in patients with SHOX gene haploinsufficiency: a meta-analysis.Semantic proximity Read ↗

Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.Semantic proximity Read ↗

SHOX in short stature syndromes.Semantic proximity Read ↗

Clinical and radiological characteristics of 22 children with SHOX anomalies and familial short stature suggestive of Léri-Weill Dyschondrosteosis.Semantic proximity Read ↗

Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency.Semantic proximity Read ↗

Clinical and genetic spectrum of SHOX deficiency: phenotypic heterogeneity and the "Jumping SHOX" phenomenon.Semantic proximity Read ↗

Short stature due to SHOX deficiency: genotype, phenotype, and therapy.Semantic proximity Read ↗

Familial growth and skeletal features associated with SHOX haploinsufficiency.Semantic proximity Read ↗

The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome.Semantic proximity Read ↗

[Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].Semantic proximity Read ↗

SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity.Semantic proximity Read ↗

Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.